Adcock Ingram – Hot or Not


Adcock Ingram is South Africa’s second largest drug maker. It has a market cap of R10.5 billion, a PE of 19.42 and a dividend yield of 2.32per cent. Guest Nesan Nair, Sasfin Securities and resident expert Paul Theron from Vestact decide whether Adcock Ingram is hot or not.

Partner Content

Absa commits to growing African trade with award-winning online platform

Absa launched its online trade finance portal, Trade Management Online, in 2019

Responsible banking in a post-COVID commodity market – Investing responsibly throughout the commodity value chain

While the alcohol sector invariably draws strong feelings from across the philosophical divide during Covid-19, what is indisputable...

A Cyber Pandemic May Be Next: How secure are you in the cloud?

The Coronavirus pandemic has influenced us in a more global way than the Cold War, affecting the environment, industry, finance, healthcare, leisure...

Subscribe to our newsletter

Sign up for free newsletters and get more CNBC AFRICA delivered to your inbox